Literature DB >> 25246121

GnRH agonist versus GnRH antagonist in ovarian stimulation: has the ongoing debate resolved?

Raoul Orvieto1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25246121     DOI： 10.1016/j.rbmo.2014.07.002

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN： 1472-6483            Impact factor:   3.828


× No keyword cloud information.
  3 in total

1.  Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?

Authors:  Weijie Xing; Haiyan Lin; Yu Li; Dongzi Yang; Wenjun Wang; Qingxue Zhang
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

2.  Uterine factors modify the association between embryo transfer depth and clinical pregnancy.

Authors:  Xiaohua Sun; Jiali Cai; Lanlan Liu; Haixiao Chen; Xiaoming Jiang; Jianzhi Ren
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

3.  Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.

Authors:  Klaus F Bühler; Robert Fischer; Patrice Verpillat; Arthur Allignol; Sandra Guedes; Emmanuelle Boutmy; Wilma Bilger; Emilia Richter; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-06-16       Impact factor: 5.211
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.